Jill Davies, MS, CCGC, Co-Founder & Chief Executive Officer

Jill Davies is Co-Founder and Chief Executive Officer for GeneMatters. Jill has more than 20 years’ experience in the genetics field, with leadership in clinical services, telehealth, product development, business development and operations. Prior to founding GeneMatters in 2016, Jill was Director of Genetics at the Medcan Clinic in Toronto where she developed and delivered leading-edge clinical genomics services. She has a special interest in the role of genomics in primary care and preventive medicine as well as the use of technology to enable access to genomic information and services.

Mark Sylvester, J.D., Chief Operating Officer

Mark is the Chief Operating Officer (COO) for GeneMatters. Prior to this role, Mark was the President & CFO of Invenshure, a med-tech incubator located in Minneapolis, MN. During his tenure, he was part of the co-founding team for 5 med & bio-tech companies, operated as their early stage CFO, and was instrumental in their go-to-market strategy. Prior to Invenshure, Mark was the CFO at The Emily Program, where he oversaw accounting, finance, payroll, and financial analytics. During his tenure, Mark sat on the board of directors, was a member of the senior leadership team, structured a debt and equity recapitalization (via private equity), and was instrumental in business development during a period of rapid growth.

Kiley Johnson, MS, LCGC, Vice President, Clinical Operations

Kiley Johnson is Vice President of Clinical Operations for GeneMatters. Prior to joining GeneMatters, Kiley was a genetic counselor at Mayo Clinic for 8.5 years where she had a broad range of clinical experience and was integral to the development of the Individualized Medicine Clinic, focused on utilizing new clinical technologies for patient care. Her clinical experiences furthered in the world of telemedicine as a Senior Genetic Counselor with InformedDNA. Kiley also has prior experience with Ariosa/Roche Diagnostics where she was a Medical and Scientific Liaison for 2 years, educating clinicians on Non-Invasive Prenatal Testing (NIPT). Kiley's special interest is bringing new genomic technologies to patient care, with an emphasis on patient education and patient-centered decision making.

Andi Hila, Vice President, Product

Andi is Vice President, Product for GeneMatters. He is a proven leader in product management of telehealth, patient engagement, population health and healthcare analytics products. Prior to joining GeneMatters, Andi led product strategy for Updox, a rapidly growing healthcare technology company. There Andi and his team delivered functionality that helped drive revenue and significant scaling of Updox’s telehealth solution. Prior to Updox, Andi worked for IBM Watson Health as a product manager and product owner. He was named as one of Ohio’s 2019 30 Under 30 in Columbus Technology and is passionate about improving patient care and increasing access through technology.

Colleen Caleshu, MS, CGC, Senior Director of Research, Cardiovascular Team Lead

Colleen is Senior Director of Research for GeneMatters and Cardiovascular Team Lead. Colleen is a pioneer in embedding genetic counseling services within cardiology. Prior to joining GeneMatters she established cardiovascular genetic counseling services for UCSF and also the Stanford Center for Inherited Cardiovascular Disease, where she built the largest cardiovascular genetic counseling team in the world. She has advanced the field of cardiovascular genetics by serving as a member of the ClinGen Cardiovascular Domain Working Group, as a contributor to the American Heart Association working committee on policy recommendations for genetics in cardiology and as chair of the National Society of Genetic Counselors Cardiovascular Genetics Special Interest Group and vice-chair of the NSGC Education Committee. In addition, she serves on the editorial board for Circulation: Genomic and Precision Medicine. Her research interests include interpretation of genetic and genomic tests in cardiology, mindfulness among genetic counselors, psychotherapeutic aspects of genetic counseling and integration of genetic counselors into cardiology.